The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
A class action lawsuit was filed against GeneDx Holdings on July 7, alleging misrepresentations regarding acquisition performance. The company's stock experienced a 49% decline during the period from April 2025 to May 2026. The lawsuit was filed by Bronstein, Gewirtz & Grossman, LLC, accusing the company of violating federal securities laws. The deadline for investors to apply for lead plaintiff status is August 3, 2026.